Global Implantable Drug Delivery Devices Market Professional Survey Report 2019

Implantable drug delivery devices are used to administer drugs and fluids without the repeated insertion of needles. This product circumvents the need for patients to be hospitalized for intravenous infusion.
Rise in incidence of chronic conditions is creating need for efficient medication delivery. Cancer results in highest number of deaths globally, raising the clinical urgency to adopt advanced alternatives, such as implantable drug delivery devices.

The global Implantable Drug Delivery Devices market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Implantable Drug Delivery Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Implantable Drug Delivery Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Implantable Drug Delivery Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Implantable Drug Delivery Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Allergan Inc.
Bayer HealthCare
Medtronic Inc.
Nucletron
Merck
PSivida Corp.
Boston Scientific Corporation
Abbott Laboratories
Bausch and Lomb Inc.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Biodegradable
Non-biodegradable

Segment by Application
Contraception
Ophthalmology
Cardiovascular
Diabetes
Oncology
Autoimmune Diseases
Others